Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	1.11e-05	2	67	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	1.11e-05	2	67	2	GO:0044017
GeneOntologyMolecularFunction	transcription coregulator activity	MED15 TSC22D1 CTBP2 WWTR1 SIN3A MAML2 PPP1R13L ARID1A CREBBP EP300	1.69e-05	562	67	10	GO:0003712
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	3.32e-05	3	67	2	GO:0043993
GeneOntologyMolecularFunction	transcription coactivator activity	TSC22D1 CTBP2 WWTR1 MAML2 ARID1A CREBBP EP300	6.90e-05	303	67	7	GO:0003713
GeneOntologyMolecularFunction	molecular adaptor activity	MED15 CNKSR1 TSC22D1 PDE4DIP CTBP2 WWTR1 SIN3A MAML2 PPP1R13L ARID1A CREBBP EP300 TAB3	4.98e-04	1356	67	13	GO:0060090
GeneOntologyMolecularFunction	chromatin binding	TICRR PHC3 AUTS2 CTBP2 SIN3A ARID1A CREBBP CIC EP300	7.77e-04	739	67	9	GO:0003682
GeneOntologyMolecularFunction	transcription coactivator binding	NR4A3 CREBBP EP300	7.92e-04	54	67	3	GO:0001223
GeneOntologyMolecularFunction	transcription corepressor activity	CTBP2 WWTR1 SIN3A PPP1R13L CREBBP	1.03e-03	229	67	5	GO:0003714
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	CREBBP EP300	1.13e-03	15	67	2	GO:0010484
GeneOntologyMolecularFunction	transcription coregulator binding	NR4A3 CTBP2 CREBBP EP300	1.26e-03	140	67	4	GO:0001221
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED15 CNKSR1 TSC22D1 CTBP2 WWTR1 SIN3A MAML2 PPP1R13L ARID1A CREBBP EP300	1.55e-03	1160	67	11	GO:0030674
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NR4A3 EP300	2.03e-03	20	67	2	GO:0035259
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	CREBBP EP300	2.24e-03	21	67	2	GO:0042975
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NR4A3 CTBP2 SIN3A ARID1A CREBBP EP300	2.73e-03	417	67	6	GO:0061629
GeneOntologyMolecularFunction	nuclear receptor binding	NR4A3 CTBP2 ARID1A EP300	3.61e-03	187	67	4	GO:0016922
GeneOntologyMolecularFunction	transcription factor binding	ARID2 NR4A3 CTBP2 SIN3A PPP1R13L ARID1A CREBBP EP300	3.61e-03	753	67	8	GO:0008134
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	1.62e-05	2	21	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	1.62e-05	2	21	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	1.62e-05	2	21	2	HP:0001042
HumanPheno	Hyperactivity	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A CREBBP CIC EP300	2.64e-05	558	21	10	HP:0000752
HumanPheno	Compulsive behaviors	HCN1 ARID2 AUTS2 SIN3A CREBBP EP300	2.99e-05	158	21	6	HP:0000722
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	4.84e-05	3	21	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	4.84e-05	3	21	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	4.84e-05	3	21	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	4.84e-05	3	21	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	4.84e-05	3	21	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	4.84e-05	3	21	2	HP:0005895
HumanPheno	Abnormal social development	WBP11 SEC24C HCN1 ARID2 CNTNAP1 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	5.80e-05	908	21	12	HP:0025732
HumanPheno	Trichiasis	CREBBP EP300	9.67e-05	4	21	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	9.67e-05	4	21	2	HP:0410266
HumanPheno	Talon cusp	CREBBP EP300	9.67e-05	4	21	2	HP:0011087
HumanPheno	Widened distal phalanges	CREBBP EP300	9.67e-05	4	21	2	HP:0006200
HumanPheno	Vascular ring	CREBBP EP300	9.67e-05	4	21	2	HP:0010775
HumanPheno	Hepatic hemangioma	CREBBP EP300	9.67e-05	4	21	2	HP:0031207
HumanPheno	Abnormal judgment	SEC24C ATXN2 HCN1 ARID2 SIN3A ECM1 CREBBP CIC EP300	1.01e-04	516	21	9	HP:5200401
HumanPheno	Short attention span	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A CREBBP CIC EP300	1.02e-04	517	21	9	HP:0000736
HumanPheno	Disinhibition	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.12e-04	807	21	11	HP:0000734
HumanPheno	Inappropriate behavior	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.12e-04	807	21	11	HP:0000719
HumanPheno	Abnormal response to social norms	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.12e-04	807	21	11	HP:5200123
HumanPheno	Social disinhibition	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.12e-04	807	21	11	HP:5200029
HumanPheno	Abnormality of the hairline	WBP11 ARID2 SIN3A PPP1R13L ARID1A CREBBP EP300	1.14e-04	294	21	7	HP:0009553
HumanPheno	Reduced attention regulation	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A CREBBP CIC EP300	1.17e-04	526	21	9	HP:5200044
HumanPheno	Abnormal thought pattern	HCN1 ARID2 AUTS2 SIN3A ECM1 CREBBP CIC EP300	1.18e-04	404	21	8	HP:5200269
HumanPheno	Autistic behavior	SEC24C HCN1 ARID2 CNTNAP1 AUTS2 SIN3A ARID1A CREBBP CIC EP300	1.44e-04	678	21	10	HP:0000729
HumanPheno	Papillary cystadenoma of the epididymis	CREBBP EP300	1.61e-04	5	21	2	HP:0009715
HumanPheno	Supernumerary cusp	CREBBP EP300	1.61e-04	5	21	2	HP:0033777
HumanPheno	Epididymal neoplasm	CREBBP EP300	1.61e-04	5	21	2	HP:0030421
HumanPheno	Abnormality of the frontal hairline	ARID2 SIN3A PPP1R13L ARID1A CREBBP EP300	1.68e-04	215	21	6	HP:0000599
HumanPheno	Wide nasal base	ARID2 SIN3A ARID1A	1.85e-04	28	21	3	HP:0012810
HumanPheno	Abnormality of the scalp hair	WBP11 ARID2 SIN3A PPP1R13L ARID1A ECM1 CREBBP EP300	1.93e-04	433	21	8	HP:0100037
HumanPheno	Broad eyebrow	SIN3A CREBBP EP300	2.06e-04	29	21	3	HP:0011229
HumanPheno	Neoplasm of the liver	POU6F2 ARID2 ARID1A CREBBP EP300	2.08e-04	140	21	5	HP:0002896
HumanPheno	Deep philtrum	ARID2 AUTS2 CREBBP EP300	2.15e-04	75	21	4	HP:0002002
HumanPheno	Congenital abnormal hair pattern	WBP11 ARID2 SIN3A PPP1R13L ARID1A CREBBP EP300	2.23e-04	327	21	7	HP:0011361
HumanPheno	Abnormally increased volition	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	2.24e-04	869	21	11	HP:5200263
HumanPheno	Abnormal nasal base norphology	ARID2 SIN3A ARID1A	2.28e-04	30	21	3	HP:0012808
HumanPheno	Contracture of the distal interphalangeal joint of the fingers	SIN3A TOR1AIP1	2.40e-04	6	21	2	HP:0009697
HumanPheno	Large foramen magnum	CREBBP EP300	2.40e-04	6	21	2	HP:0002700
HumanPheno	Abnormal scalp morphology	WBP11 ARID2 SIN3A PPP1R13L ARID1A ECM1 CREBBP EP300	2.52e-04	450	21	8	HP:0001965
HumanPheno	Thick eyebrow	ARID2 AUTS2 ARID1A CREBBP EP300	3.25e-04	154	21	5	HP:0000574
HumanPheno	Diagnostic behavioral phenotype	SEC24C HCN1 ARID2 CNTNAP1 AUTS2 SIN3A ARID1A CREBBP CIC EP300	3.29e-04	747	21	10	HP:0025783
HumanPheno	Deviated nasal septum	CREBBP EP300	3.36e-04	7	21	2	HP:0004411
HumanPheno	Short philtrum	SEC24C ARID2 AUTS2 SIN3A ARID1A CREBBP	4.08e-04	253	21	6	HP:0000322
HumanPheno	Maladaptive fear-related cognitions	SEC24C ATXN2 HCN1 ARID2 SIN3A CREBBP CIC EP300	4.12e-04	483	21	8	HP:5200230
HumanPheno	Anxiety	SEC24C ATXN2 HCN1 ARID2 SIN3A CREBBP CIC EP300	4.12e-04	483	21	8	HP:0000739
HumanPheno	Auditory sensitivity	AUTS2 CREBBP EP300	4.29e-04	37	21	3	HP:0025112
HumanPheno	Restricted or repetitive behaviors or interests	HCN1 ARID2 AUTS2 SIN3A CREBBP CIC EP300	4.64e-04	368	21	7	HP:0031432
HumanPheno	Retrognathia	WBP11 ARID2 CNTNAP1 AUTS2 SIN3A CREBBP EP300	5.21e-04	375	21	7	HP:0000278
HumanPheno	Spina bifida	WBP11 SEC24C SIN3A CREBBP EP300	5.28e-04	171	21	5	HP:0002414
HumanPheno	Hypospadias	POU6F2 SEC24C ARID2 SIN3A ARID1A CREBBP EP300	5.38e-04	377	21	7	HP:0000047
HumanPheno	Perseverative thought	HCN1 ARID2 AUTS2 SIN3A CREBBP CIC EP300	5.38e-04	377	21	7	HP:0030223
HumanPheno	Abnormal experience of reality	SEC24C ATXN2 HCN1 ARID2 SIN3A ECM1 CREBBP CIC EP300	5.71e-04	646	21	9	HP:5200423
HumanPheno	Pilomatrixoma	CREBBP EP300	5.73e-04	9	21	2	HP:0030434
HumanPheno	Cervical cord compression	CREBBP EP300	5.73e-04	9	21	2	HP:0002341
HumanPheno	Impairment in personality functioning	WBP11 SEC24C ATXN2 HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	5.76e-04	1141	21	12	HP:0031466
HumanPheno	Disordered formal thought process	HCN1 ARID2 AUTS2 SIN3A CREBBP CIC EP300	6.21e-04	386	21	7	HP:0025769
HumanPheno	Thick vermilion border	ARID2 CNTNAP1 AUTS2 SIN3A ARID1A ECM1	6.90e-04	279	21	6	HP:0012471
HumanPheno	Frontal hirsutism	CREBBP EP300	7.14e-04	10	21	2	HP:0011335
HumanPheno	Sporadic	ATXN2 SIN3A CREBBP EP300	7.24e-04	103	21	4	HP:0003745
HumanPheno	Displacement of the urethral meatus	POU6F2 SEC24C ARID2 SIN3A ARID1A CREBBP EP300	7.36e-04	397	21	7	HP:0100627
HumanPheno	Abnormal male urethral meatus morphology	POU6F2 SEC24C ARID2 SIN3A ARID1A CREBBP EP300	7.59e-04	399	21	7	HP:0032076
HumanPheno	Spinal dysraphism	WBP11 SEC24C SIN3A CREBBP EP300	7.77e-04	186	21	5	HP:0010301
HumanPheno	Abnormal fear-induced behavior	SEC24C ATXN2 HCN1 ARID2 SIN3A CREBBP CIC EP300	8.58e-04	538	21	8	HP:0100852
HumanPheno	Abnormal subclavian artery morphology	CREBBP EP300	8.71e-04	11	21	2	HP:0031251
HumanPheno	Atrial septal defect	ROBO4 SEC24C ARID2 AUTS2 PPP1R13L ARID1A CREBBP EP300	8.90e-04	541	21	8	HP:0001631
HumanPheno	Abnormality of the atrial septum	ROBO4 SEC24C ARID2 AUTS2 PPP1R13L ARID1A CREBBP EP300	8.90e-04	541	21	8	HP:0001630
HumanPheno	Abnormal atrial septum morphology	ROBO4 SEC24C ARID2 AUTS2 PPP1R13L ARID1A CREBBP EP300	9.24e-04	544	21	8	HP:0011994
HumanPheno	Attention deficit hyperactivity disorder	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A CIC	9.34e-04	413	21	7	HP:0007018
HumanPheno	Reduced impulse control	WBP11 SEC24C HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.06e-03	1032	21	11	HP:5200045
HumanPheno	Abnormality of mouth size	SEC24C ARID2 AUTS2 SIN3A ARID1A CREBBP EP300	1.11e-03	425	21	7	HP:0011337
HumanPheno	Narrow palate	ARID2 CNTNAP1 SIN3A CREBBP EP300	1.13e-03	202	21	5	HP:0000189
HumanPheno	Facial grimacing	CREBBP EP300	1.23e-03	13	21	2	HP:0000273
HumanPheno	Keloids	CREBBP EP300	1.23e-03	13	21	2	HP:0010562
HumanPheno	Aplasia/Hypoplasia of the earlobes	SEC24C CREBBP EP300	1.24e-03	53	21	3	HP:0009906
HumanPheno	Polyhydramnios	SEC24C CNTNAP1 SIN3A PPP1R13L CREBBP EP300	1.24e-03	312	21	6	HP:0001561
HumanPheno	Bicuspid aortic valve	ROBO4 PPP1R13L CREBBP EP300	1.25e-03	119	21	4	HP:0001647
HumanPheno	Dislocated radial head	COL27A1 CREBBP EP300	1.31e-03	54	21	3	HP:0003083
HumanPheno	Abnormal aortic valve cusp morphology	ROBO4 PPP1R13L CREBBP EP300	1.33e-03	121	21	4	HP:0031567
HumanPheno	Short palpebral fissure	AUTS2 SIN3A CREBBP EP300	1.37e-03	122	21	4	HP:0012745
HumanPheno	Abnormality of the pharynx	SEC24C ARID2 CNTNAP1 ARID1A CREBBP EP300	1.42e-03	320	21	6	HP:0000600
HumanPheno	Duplication of phalanx of hallux	CREBBP EP300	1.43e-03	14	21	2	HP:0010066
HumanPheno	Hypoplastic aortic arch	CREBBP EP300	1.43e-03	14	21	2	HP:0012304
HumanPheno	Parietal foramina	CREBBP EP300	1.43e-03	14	21	2	HP:0002697
HumanPheno	Hypoplastic fifth fingernail	ARID2 ARID1A	1.43e-03	14	21	2	HP:0008398
HumanPheno	Non-epileptic seizure	SIN3A CREBBP EP300	1.45e-03	56	21	3	HP:0033052
HumanPheno	Abnormal motivation	WBP11 SEC24C ATXN2 HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.53e-03	1263	21	12	HP:5200275
HumanPheno	Abnormal volitional state	WBP11 SEC24C ATXN2 HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.53e-03	1263	21	12	HP:0025780
HumanPheno	Abnormality of the radial head	COL27A1 CREBBP EP300	1.53e-03	57	21	3	HP:0003995
HumanPheno	Duplication of phalanx of toe	CREBBP EP300	1.65e-03	15	21	2	HP:0010181
HumanPheno	Social and occupational deterioration	CREBBP EP300	1.65e-03	15	21	2	HP:0007086
HumanPheno	Square face	CREBBP EP300	1.88e-03	16	21	2	HP:0000321
HumanPheno	Abnormality of the urethra	POU6F2 SEC24C ARID2 SIN3A ARID1A CREBBP EP300	1.89e-03	465	21	7	HP:0000795
HumanPheno	Recurrent maladaptive behavior	WBP11 SEC24C ATXN2 HCN1 ARID2 AUTS2 SIN3A ARID1A ECM1 CREBBP CIC EP300	1.90e-03	1293	21	12	HP:5200241
HumanPheno	Abnormal incisor morphology	PPP1R13L CREBBP EP300	1.95e-03	62	21	3	HP:0011063
HumanPheno	Abnormality of the humeroradial joint	COL27A1 CREBBP EP300	1.95e-03	62	21	3	HP:0100744
HumanPheno	Thick lower lip vermilion	ARID2 SIN3A ARID1A ECM1	2.04e-03	136	21	4	HP:0000179
Domain	NPIP	NPIPB15 NPIPB13 NPIPB9 NPIPA5 NPIPA1 NPIPB3 NPIPA3 NPIPB5 NPIPA7 NPIPB2	1.14e-21	14	80	10	IPR009443
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	3.02e-07	4	80	3	PF14914
Domain	LRRC37_N	LRRC37A LRRC37A3 LRRC37A2	3.02e-07	4	80	3	IPR032754
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	3.02e-07	4	80	3	IPR029423
Domain	LRRC37	LRRC37A LRRC37A3 LRRC37A2	3.02e-07	4	80	3	PF15779
Domain	LRRC37A/B-like	LRRC37A LRRC37A3 LRRC37A2	3.02e-07	4	80	3	IPR015753
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	1.81e-05	2	80	2	IPR014744
Domain	HAT_KAT11	CREBBP EP300	1.81e-05	2	80	2	PF08214
Domain	KIX	CREBBP EP300	1.81e-05	2	80	2	PS50952
Domain	SM_dom_ATX	ATXN2L ATXN2	1.81e-05	2	80	2	IPR025852
Domain	ZnF_TAZ	CREBBP EP300	1.81e-05	2	80	2	SM00551
Domain	CBP_P300_HAT	CREBBP EP300	1.81e-05	2	80	2	IPR031162
Domain	DUF902	CREBBP EP300	1.81e-05	2	80	2	PF06001
Domain	-	CREBBP EP300	1.81e-05	2	80	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	1.81e-05	2	80	2	IPR010303
Domain	-	CREBBP EP300	1.81e-05	2	80	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	1.81e-05	2	80	2	PF09030
Domain	-	CREBBP EP300	1.81e-05	2	80	2	1.10.246.20
Domain	zf-TAZ	CREBBP EP300	1.81e-05	2	80	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	1.81e-05	2	80	2	PS50134
Domain	LsmAD	ATXN2L ATXN2	1.81e-05	2	80	2	PF06741
Domain	LsmAD_domain	ATXN2L ATXN2	1.81e-05	2	80	2	IPR009604
Domain	SM-ATX	ATXN2L ATXN2	1.81e-05	2	80	2	PF14438
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	1.81e-05	2	80	2	IPR013178
Domain	LsmAD	ATXN2L ATXN2	1.81e-05	2	80	2	SM01272
Domain	KAT11	CREBBP EP300	1.81e-05	2	80	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	1.81e-05	2	80	2	IPR000197
Domain	KIX_dom	CREBBP EP300	1.81e-05	2	80	2	IPR003101
Domain	KIX	CREBBP EP300	1.81e-05	2	80	2	PF02172
Domain	CBP_P300_HAT	CREBBP EP300	1.81e-05	2	80	2	PS51727
Domain	Tensin_PTB	TNS2 TNS4	1.08e-04	4	80	2	IPR033929
Domain	Nuc_rcpt_coact	CREBBP EP300	2.69e-04	6	80	2	IPR009110
Domain	PTB	TNS2 TNS4	4.99e-04	8	80	2	PF08416
Domain	PTB	TNS2 TNS4	4.99e-04	8	80	2	IPR013625
Domain	PAM2	ATXN2L ATXN2	6.40e-04	9	80	2	PF07145
Domain	PPASE_TENSIN	TNS2 TNS4	6.40e-04	9	80	2	PS51181
Domain	Ataxin-2_C	ATXN2L ATXN2	6.40e-04	9	80	2	IPR009818
Domain	-	ARID2 ARID1A	1.83e-03	15	80	2	1.10.150.60
Domain	BRIGHT	ARID2 ARID1A	1.83e-03	15	80	2	SM00501
Domain	ARID_dom	ARID2 ARID1A	1.83e-03	15	80	2	IPR001606
Domain	ARID	ARID2 ARID1A	1.83e-03	15	80	2	PS51011
Domain	ARID	ARID2 ARID1A	1.83e-03	15	80	2	PF01388
Domain	ZZ	CREBBP EP300	2.65e-03	18	80	2	PF00569
Domain	ZF_ZZ_2	CREBBP EP300	2.65e-03	18	80	2	PS50135
Domain	ZF_ZZ_1	CREBBP EP300	2.65e-03	18	80	2	PS01357
Domain	Znf_ZZ	CREBBP EP300	2.96e-03	19	80	2	IPR000433
Domain	ZnF_ZZ	CREBBP EP300	2.96e-03	19	80	2	SM00291
Domain	Bromodomain_CS	CREBBP EP300	5.51e-03	26	80	2	IPR018359
Domain	FHA	STARD9 MKI67	6.37e-03	28	80	2	SM00240
Domain	FHA	STARD9 MKI67	7.77e-03	31	80	2	PF00498
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	PHC3 ARID2 AUTS2 ARID1A EP300	1.48e-07	37	48	5	M27797
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	PHC3 ARID2 AUTS2 NR4A3 SIN3A ARID1A CREBBP EP300	1.20e-06	237	48	8	M27786
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	PHC3 AUTS2 ARID1A EP300	5.09e-06	34	48	4	MM15531
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 CREBBP EP300	1.31e-05	14	48	3	M27808
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	PHC3 SIN3A CREBBP EP300	1.45e-05	44	48	4	M27295
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	CTBP2 MAML2 CREBBP EP300	1.90e-05	47	48	4	M7946
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	MAML2 CREBBP EP300	2.01e-05	16	48	3	M27121
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP EP300	4.06e-05	20	48	3	M27881
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP EP300	5.45e-05	22	48	3	MM1370
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP EP300	7.13e-05	24	48	3	M13404
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP EP300	8.08e-05	25	48	3	M27880
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.13e-04	5	48	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	1.13e-04	5	48	2	M48020
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	1.13e-04	5	48	2	M27228
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	1.13e-04	5	48	2	M48023
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	PHC3 AUTS2 SIN3A ARID1A EP300	1.66e-04	153	48	5	MM15522
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.69e-04	6	48	2	M22062
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	MED15 SIN3A CREBBP EP300	1.70e-04	82	48	4	M2
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	PHC3 ZKSCAN8 AUTS2 NR4A3 WWTR1 SIN3A MAML2 PPP1R13L ARID1A EP300	2.15e-04	768	48	10	MM14851
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	2.36e-04	7	48	2	MM1573
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	WWTR1 MAML2 CREBBP EP300	3.12e-04	96	48	4	M27784
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	3.14e-04	8	48	2	M22058
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	3.14e-04	8	48	2	M48022
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	CREBBP EP300	3.14e-04	8	48	2	M48024
Pathway	REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES	CREBBP EP300	3.14e-04	8	48	2	M46443
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	PHC3 SIN3A EP300	3.35e-04	40	48	3	MM15000
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	MAML2 CREBBP EP300	3.87e-04	42	48	3	M17541
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	CREBBP EP300	4.03e-04	9	48	2	M47451
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 EP300	5.02e-04	10	48	2	MM15535
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	CREBBP EP300	5.02e-04	10	48	2	M27945
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	MED15 PHC3 ARID2 ZKSCAN8 AUTS2 NR4A3 WWTR1 SIN3A MAML2 PPP1R13L ARID1A CREBBP EP300	5.52e-04	1387	48	13	M734
Pathway	PID_HES_HEY_PATHWAY	MAML2 CREBBP EP300	5.75e-04	48	48	3	M288
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP EP300	5.75e-04	48	48	3	M611
Pathway	REACTOME_SIGNALING_BY_NOTCH3	MAML2 CREBBP EP300	6.12e-04	49	48	3	M618
Pathway	REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	ALPK1 TAB3	6.12e-04	11	48	2	M29827
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	6.12e-04	11	48	2	MM1521
Pathway	REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES	CREBBP EP300	6.12e-04	11	48	2	M48021
Pathway	REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING	SIN3A EP300	6.12e-04	11	48	2	M42523
Pathway	REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	ALPK1 TAB3	6.12e-04	11	48	2	MM15668
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	CREBBP EP300	6.12e-04	11	48	2	M26924
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	MED15 SIN3A CREBBP EP300	6.83e-04	118	48	4	M27316
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	7.33e-04	12	48	2	M7968
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	CREBBP EP300	7.33e-04	12	48	2	M27765
Pathway	REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 EP300	7.33e-04	12	48	2	M27159
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	MAML2 CREBBP EP300	1.00e-03	58	48	3	M29616
Pathway	PID_P53_REGULATION_PATHWAY	PPP1R13L CREBBP EP300	1.05e-03	59	48	3	M261
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.16e-03	15	48	2	MM1339
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.16e-03	15	48	2	M10183
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.16e-03	15	48	2	MM1439
Pathway	KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27	AUTS2 EP300	1.16e-03	15	48	2	M47973
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	CREBBP EP300	1.16e-03	15	48	2	M953
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	MYRIP SIN3A ARID1A CREBBP	1.19e-03	137	48	4	M48232
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.32e-03	16	48	2	M1296
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.32e-03	16	48	2	MM1420
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	MYRIP SIN3A	1.32e-03	16	48	2	MM17241
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.32e-03	16	48	2	M8516
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	CREBBP EP300	1.32e-03	16	48	2	M27940
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ARID1A CREBBP EP300	1.40e-03	65	48	3	M39682
Pathway	PID_HDAC_CLASSI_PATHWAY	SIN3A CREBBP EP300	1.46e-03	66	48	3	M101
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	SIN3A CREBBP EP300	1.46e-03	66	48	3	M27938
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	1.49e-03	17	48	2	MM1509
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	CREBBP EP300	1.49e-03	17	48	2	M48025
Pathway	REACTOME_FORMATION_OF_PARAXIAL_MESODERM	MAML2 CREBBP EP300	1.66e-03	69	48	3	M46439
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAML2 EP300	1.68e-03	18	48	2	MM14775
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	CREBBP EP300	1.68e-03	18	48	2	M26942
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	1.87e-03	19	48	2	M18933
Pathway	REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES	CREBBP EP300	1.87e-03	19	48	2	M46442
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	PHC3 ZKSCAN8 AUTS2 NR4A3 WWTR1 SIN3A MAML2 PPP1R13L ARID1A EP300	1.99e-03	1022	48	10	MM15436
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAML2 CREBBP EP300	2.03e-03	74	48	3	M616
Pathway	WP_ESTROGEN_SIGNALING	SIN3A CREBBP EP300	2.27e-03	77	48	3	MM15934
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	CREBBP EP300	2.29e-03	21	48	2	M39593
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	CREBBP EP300	2.29e-03	21	48	2	M27485
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	2.51e-03	22	48	2	MM1443
Pathway	WP_HEDGEHOG_SIGNALING_PATHWAY	SIN3A CREBBP	2.51e-03	22	48	2	MM15924
Pathway	REACTOME_SIGNALING_BY_NOTCH4	MAML2 CREBBP EP300	2.72e-03	82	48	3	M594
Pathway	WP_DELTANOTCH_SIGNALING_PATHWAY	SIN3A MAML2 EP300	2.72e-03	82	48	3	MM15922
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	2.74e-03	23	48	2	M2821
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	MED15 CREBBP EP300	2.91e-03	84	48	3	M1008
Pathway	PID_CMYB_PATHWAY	SIN3A CREBBP EP300	2.91e-03	84	48	3	M195
Pathway	BIOCARTA_CARM_ER_PATHWAY	CREBBP EP300	3.50e-03	26	48	2	M2499
Pathway	PID_HDAC_CLASSIII_PATHWAY	CREBBP EP300	3.50e-03	26	48	2	M32
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	SIN3A CREBBP EP300	3.65e-03	91	48	3	M39700
Pathway	REACTOME_SUMOYLATION	PHC3 SIN3A CREBBP EP300	3.84e-03	189	48	4	M27214
Pathway	REACTOME_ATTENUATION_PHASE	CREBBP EP300	4.06e-03	28	48	2	M27254
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	MAML2 CREBBP	4.06e-03	28	48	2	M6177
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	MYRIP SIN3A ARID1A	4.12e-03	95	48	3	M48268
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	NR4A3 SIN3A EP300	4.24e-03	96	48	3	M27792
Pathway	REACTOME_RSV_HOST_INTERACTIONS	MED15 CREBBP EP300	4.49e-03	98	48	3	M48247
Pathway	PID_RETINOIC_ACID_PATHWAY	CREBBP EP300	4.65e-03	30	48	2	M207
Pathway	REACTOME_SIGNALING_BY_ALK	SIN3A EP300	4.65e-03	30	48	2	M42517
Pathway	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	CREBBP EP300	4.65e-03	30	48	2	M936
Pathway	WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY	CTBP2 CREBBP EP300	4.89e-03	101	48	3	MM15829
Pathway	WP_WNT_SIGNALING_AND_PLURIPOTENCY	CTBP2 CREBBP EP300	4.89e-03	101	48	3	M39387
Pathway	WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR	CREBBP EP300	5.28e-03	32	48	2	M39521
Pathway	REACTOME_SIGNALING_BY_NOTCH2	MAML2 EP300	5.60e-03	33	48	2	M604
Pathway	WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA	CREBBP EP300	5.94e-03	34	48	2	M39771
Pathway	PID_HIF2PATHWAY	CREBBP EP300	5.94e-03	34	48	2	M44
Pathway	REACTOME_ADIPOGENESIS	MED15 CREBBP EP300	6.20e-03	110	48	3	M48259
Pathway	REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES	CREBBP EP300	6.29e-03	35	48	2	M48246
Pathway	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	WWTR1 EP300	6.64e-03	36	48	2	M633
Pubmed	Human transcription factor protein interaction networks.	MED15 PHC3 WBP11 UBAP2 SMG7 GSE1 ATXN2 TTC31 ARID2 MKI67 AUTS2 CTBP2 YBX3 SIN3A USP54 R3HDM1 ARID1A CREBBP INO80D PRRC2A CIC EP300 EMSY TAB3	3.57e-14	1429	85	24	35140242
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	MED15 ATXN2L GSE1 AUTS2 R3HDM1 FOXJ3 CREBBP CIC EP300 TAB3	4.45e-12	152	85	10	38360978
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MED15 ATXN2L UBAP2 SMG7 ARID2 WWTR1 SIN3A ARID1A CREBBP PRRC2A EP300 EMSY TAB3	8.60e-10	549	85	13	38280479
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	MED15 ATXN2L WBP11 PRMT8 ATXN2 PDE4DIP TNS2 CTBP2 USP54 R3HDM1 ECM1 PRRC2A CIC	2.93e-09	608	85	13	16713569
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	PHC3 ARID2 AUTS2 CTBP2 SIN3A ARID1A CREBBP EP300	5.17e-09	157	85	8	30186101
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MED15 ROBO4 CNKSR1 GSE1 LRRC37A3 ARID2 CSRP2 NR4A3 ARID1A FOXJ3 CREBBP CIC EP300	5.21e-09	638	85	13	31182584
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MED15 ATXN2L WBP11 GSE1 ATXN2 ARID2 MKI67 SIN3A ARID1A FOXJ3 CREBBP INO80D PRRC2A CIC EP300 EMSY	9.50e-09	1103	85	16	34189442
Pubmed	Interaction network of human early embryonic transcription factors.	MED15 GSE1 ARID2 MKI67 AUTS2 CTBP2 ARID1A CREBBP EP300 EMSY	1.54e-08	351	85	10	38297188
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MED15 SMG7 GSE1 ATXN2 AUTS2 WWTR1 ARID1A CREBBP TOR1AIP1 CIC EP300	1.59e-08	457	85	11	32344865
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	GSE1 CTBP2 ARID1A CREBBP EP300	4.76e-08	40	85	5	34585037
Pubmed	Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.	NPIPA5 NPIPA1 NPIPA3	5.63e-08	4	85	3	18055785
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A LRRC37A3 LRRC37A2	5.63e-08	4	85	3	22419166
Pubmed	A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.	PPP1R13L CREBBP EP300	1.40e-07	5	85	3	25675294
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SMG7 ATXN2 MKI67 USP54 R3HDM1 ARID1A TOR1AIP1 TAB3	2.80e-07	263	85	8	34702444
Pubmed	Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.	MAML2 CREBBP EP300	2.80e-07	6	85	3	15961999
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L PHC3 GSE1 SEC24C SIPA1L1 MKI67 AFF1 YBX3 SIN3A PRRC2A CIC EMSY	4.04e-07	774	85	12	15302935
Pubmed	A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.	WWTR1 CREBBP EP300	4.90e-07	7	85	3	16332960
Pubmed	A unique SUMO-2-interacting motif within LANA is essential for KSHV latency.	SIN3A CREBBP EP300	4.90e-07	7	85	3	24278015
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L PHC3 WBP11 UBAP2 ATXN2 ARID2 MKI67 YBX3 ARID1A PRRC2A TOR1AIP1 CIC EMSY	5.47e-07	954	85	13	36373674
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	MED15 PHC3 ARID2 AUTS2 CTBP2 USP54 ARID1A CREBBP EP300	5.88e-07	398	85	9	35016035
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	FAM171A1 WBP11 UBAP2 SEC24C ATXN2 HCN1 SIPA1L1 CNTNAP1 PDE4DIP CTBP2 SYNPO PRRC2A EMSY	6.08e-07	963	85	13	28671696
Pubmed	Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression.	SIN3A CREBBP EP300	7.82e-07	8	85	3	20935208
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	MED15 WBP11 SEC24C CSRP2 R3HDM1 ARID1A CREBBP CIC EP300	1.01e-06	425	85	9	24999758
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	ATXN2L UBAP2 SEC24C ATXN2 SIPA1L1 MKI67 YBX3 PRRC2A	1.09e-06	315	85	8	26777405
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PHC3 UBAP2 ATXN2 ARID2 AFF1 SIN3A MAML2 FOXJ3 CIC	1.12e-06	430	85	9	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FAM171A1 ATXN2L UBAP2 STARD9 SIPA1L1 WWTR1 ALPK1 USP54 R3HDM1 MAP3K6 CIC TAB3	1.23e-06	861	85	12	36931259
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A LRRC37A3 LRRC37A2	1.67e-06	10	85	3	23064749
Pubmed	Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages.	SIN3A CREBBP EP300	1.67e-06	10	85	3	25314079
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CNKSR1 WBP11 HCN1 SIPA1L1 CNTNAP1 PDE4DIP MYRIP SYNPO USP54 R3HDM1 ARID1A CREBBP PRRC2A EP300	2.70e-06	1285	85	14	35914814
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L PHC3 UBAP2 SMG7 GSE1 ARID2 MKI67 SIN3A PRRC2A TOR1AIP1 CIC EMSY	2.86e-06	934	85	12	33916271
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED15 GSE1 SIN3A ARID1A CREBBP CIC EMSY	4.41e-06	268	85	7	33640491
Pubmed	E protein silencing by the leukemogenic AML1-ETO fusion protein.	SIN3A CREBBP EP300	5.03e-06	14	85	3	15333839
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	ATXN2L ATXN2 MKI67 SIN3A PRRC2A	5.10e-06	101	85	5	26949739
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	5.90e-06	2	85	2	27881875
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	5.90e-06	2	85	2	34845315
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	5.90e-06	2	85	2	19729597
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	5.90e-06	2	85	2	15860545
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	5.90e-06	2	85	2	29460469
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	5.90e-06	2	85	2	24551300
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	5.90e-06	2	85	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	5.90e-06	2	85	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	5.90e-06	2	85	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	5.90e-06	2	85	2	30135524
Pubmed	Positive selection of a gene family during the emergence of humans and African apes.	NPIPA1 NPIPA8	5.90e-06	2	85	2	11586358
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	5.90e-06	2	85	2	39287984
Pubmed	Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2.	CTBP2 EP300	5.90e-06	2	85	2	16356938
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	5.90e-06	2	85	2	16596650
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	5.90e-06	2	85	2	29217654
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	5.90e-06	2	85	2	20717166
Pubmed	Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.	CREBBP EP300	5.90e-06	2	85	2	10049825
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	5.90e-06	2	85	2	27380996
Pubmed	CREBBP and p300 lysine acetyl transferases in the DNA damage response.	CREBBP EP300	5.90e-06	2	85	2	29170789
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	5.90e-06	2	85	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	5.90e-06	2	85	2	11559821
Pubmed	Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.	CREBBP EP300	5.90e-06	2	85	2	21555743
Pubmed	CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.	CREBBP EP300	5.90e-06	2	85	2	12646247
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	5.90e-06	2	85	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	5.90e-06	2	85	2	19822209
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	5.90e-06	2	85	2	24522976
Pubmed	Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.	CREBBP EP300	5.90e-06	2	85	2	11867645
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	5.90e-06	2	85	2	21847097
Pubmed	Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue.	CREBBP EP300	5.90e-06	2	85	2	11963968
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	5.90e-06	2	85	2	34813504
Pubmed	Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.	CREBBP EP300	5.90e-06	2	85	2	9528808
Pubmed	Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines.	CREBBP EP300	5.90e-06	2	85	2	12696060
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	5.90e-06	2	85	2	20301699
Pubmed	CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain.	CREBBP EP300	5.90e-06	2	85	2	36109165
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	5.90e-06	2	85	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	5.90e-06	2	85	2	37816914
Pubmed	Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.	CREBBP EP300	5.90e-06	2	85	2	12242694
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	5.90e-06	2	85	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	5.90e-06	2	85	2	10918613
Pubmed	CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.	CREBBP EP300	5.90e-06	2	85	2	31182547
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	5.90e-06	2	85	2	35502657
Pubmed	Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.	CREBBP EP300	5.90e-06	2	85	2	30635043
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	5.90e-06	2	85	2	31898871
Pubmed	Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.	CREBBP EP300	5.90e-06	2	85	2	27648933
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	5.90e-06	2	85	2	30888860
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	5.90e-06	2	85	2	27881443
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	5.90e-06	2	85	2	19272189
Pubmed	Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis.	CREBBP EP300	5.90e-06	2	85	2	10610021
Pubmed	Emerging roles of p300/CBP in autophagy and autophagy-related human disorders.	CREBBP EP300	5.90e-06	2	85	2	37314181
Pubmed	Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.	CREBBP EP300	5.90e-06	2	85	2	12397173
Pubmed	CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.	CREBBP EP300	5.90e-06	2	85	2	15641773
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	5.90e-06	2	85	2	32690000
Pubmed	Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.	CREBBP EP300	5.90e-06	2	85	2	9733868
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	5.90e-06	2	85	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	5.90e-06	2	85	2	21803292
Pubmed	Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.	ATXN2L ATXN2	5.90e-06	2	85	2	8896555
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	5.90e-06	2	85	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	5.90e-06	2	85	2	24089570
Pubmed	Rubinstein-Taybi syndrome in Chinese population with four novel mutations.	CREBBP EP300	5.90e-06	2	85	2	33063428
Pubmed	EP300/CBP is crucial for cAMP-PKA pathway to alleviate podocyte dedifferentiation via targeting Notch3 signaling.	CREBBP EP300	5.90e-06	2	85	2	34506759
Pubmed	Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms.	CREBBP EP300	5.90e-06	2	85	2	22177454
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	5.90e-06	2	85	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	5.90e-06	2	85	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	5.90e-06	2	85	2	22303793
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	5.90e-06	2	85	2	34732714
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	5.90e-06	2	85	2	34019788
Pubmed	Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation.	MKI67 CREBBP EP300	6.28e-06	15	85	3	14517255
Interaction	TLE3 interactions	MED15 PHC3 SMG7 GSE1 ARID2 AUTS2 CTBP2 ARID1A CREBBP INO80D CIC EP300 EMSY	1.69e-09	376	77	13	int:TLE3
Interaction	TEAD1 interactions	GSE1 ARID2 NR4A3 WWTR1 SIN3A ARID1A CREBBP CIC EP300	2.33e-08	176	77	9	int:TEAD1
Interaction	EYA4 interactions	MED15 ATXN2L GSE1 AUTS2 R3HDM1 FOXJ3 CREBBP CIC EP300 TAB3	2.92e-08	243	77	10	int:EYA4
Interaction	WWTR1 interactions	ATXN2L UBAP2 SMG7 ARID2 WWTR1 SIN3A ARID1A CREBBP PRRC2A EP300 EMSY TAB3	6.54e-08	422	77	12	int:WWTR1
Interaction	CPEB1 interactions	UBAP2 SMG7 ATXN2 TTC31 YBX3 USP54 R3HDM1 PRRC2A	8.63e-08	146	77	8	int:CPEB1
Interaction	YTHDF2 interactions	ATXN2L UBAP2 SMG7 ATXN2 MKI67 YBX3 R3HDM1 CREBBP PRRC2A CIC	3.00e-07	312	77	10	int:YTHDF2
Interaction	NUP35 interactions	MED15 SMG7 GSE1 ATXN2 AUTS2 WWTR1 ARID1A CREBBP CIC EP300 PDZD2	6.03e-07	424	77	11	int:NUP35
Interaction	HNF1B interactions	POU6F2 GSE1 ARID2 USP54 ARID1A CREBBP CIC EP300	6.50e-07	190	77	8	int:HNF1B
Interaction	KLF5 interactions	GSE1 ARID2 WWTR1 ARID1A CREBBP PRRC2A CIC EP300	7.91e-07	195	77	8	int:KLF5
Interaction	FEV interactions	PHC3 GSE1 ARID2 ARID1A CREBBP CIC EP300 EMSY	1.07e-06	203	77	8	int:FEV
Interaction	BTRC interactions	ATXN2L UBAP2 SMG7 CSRP2 MKI67 TNS2 WWTR1 YBX3 USP54 ARID1A MAP3K6 PRRC2A EP300 INKA1	1.22e-06	775	77	14	int:BTRC
Interaction	CNOT3 interactions	MED15 ATXN2L UBAP2 SMG7 CREBBP PRRC2A EP300 TAB3	1.24e-06	207	77	8	int:CNOT3
Interaction	SOX9 interactions	PHC3 ARID2 ARID1A CREBBP CIC EP300	1.91e-06	97	77	6	int:SOX9
Interaction	MEX3B interactions	ATXN2L UBAP2 SMG7 ATXN2 YBX3 USP54 R3HDM1 PRRC2A	2.09e-06	222	77	8	int:MEX3B
Interaction	SMG7 interactions	SMG7 GSE1 ATXN2 WWTR1 YBX3 R3HDM1 ARID1A CREBBP PRRC2A	3.50e-06	319	77	9	int:SMG7
Interaction	GCM1 interactions	GSE1 ARID1A CREBBP CIC EP300	6.17e-06	68	77	5	int:GCM1
Interaction	ALG13 interactions	SMG7 GSE1 ATXN2 R3HDM1 ARID1A PRRC2A EP300	6.39e-06	183	77	7	int:ALG13
Interaction	LSM14A interactions	ATXN2L PRMT8 UBAP2 SMG7 ATXN2 R3HDM1 PRRC2A CIC	6.72e-06	260	77	8	int:LSM14A
Interaction	YY1 interactions	ATXN2L PHC3 ARID2 MKI67 SIN3A CREBBP INO80D CIC EP300 EMSY	8.68e-06	454	77	10	int:YY1
Interaction	RUNX2 interactions	MED15 CTBP2 WWTR1 CREBBP CIC EP300	8.74e-06	126	77	6	int:RUNX2
Interaction	R3HDM2 interactions	UBAP2 SMG7 ATXN2 USP54 R3HDM1 PRRC2A	1.00e-05	129	77	6	int:R3HDM2
Interaction	RBBP4 interactions	MED15 ROBO4 GSE1 CTBP2 YBX3 SIN3A ARID1A CREBBP CIC EP300 EMSY	1.09e-05	573	77	11	int:RBBP4
Interaction	ZEB1 interactions	NR4A3 CTBP2 WWTR1 YBX3 USP54 CREBBP EP300	1.14e-05	200	77	7	int:ZEB1
Interaction	KLF1 interactions	SIN3A ARID1A CREBBP EP300	1.18e-05	37	77	4	int:KLF1
Interaction	FBXW11 interactions	PRMT8 SMG7 SIPA1L1 TNS2 CTBP2 WWTR1 USP54 MAP3K6 PRRC2A INKA1	1.24e-05	473	77	10	int:FBXW11
Interaction	ACTL6A interactions	MED15 ARID2 WWTR1 SIN3A ARID1A INO80D CIC EP300	1.45e-05	289	77	8	int:ACTL6A
Interaction	KLF15 interactions	MED15 GSE1 ARID2 CREBBP PRRC2A CIC EP300 EMSY	1.49e-05	290	77	8	int:KLF15
Interaction	CEBPA interactions	MED15 ATXN2L WBP11 GSE1 ATXN2 ARID2 MKI67 SIN3A ARID1A FOXJ3 CREBBP INO80D PRRC2A CIC EP300 EMSY	1.56e-05	1245	77	16	int:CEBPA
Interaction	NR3C1 interactions	MED15 ROBO4 CNKSR1 GSE1 LRRC37A3 ARID2 CSRP2 NR4A3 TNS4 ARID1A FOXJ3 CREBBP CIC EP300	1.69e-05	974	77	14	int:NR3C1
Interaction	ASB3 interactions	GSE1 ATXN2 TNS2 USP54 CIC	1.74e-05	84	77	5	int:ASB3
Interaction	ZC3H7A interactions	ATXN2L UBAP2 SMG7 ATXN2 TTC31 R3HDM1 PRRC2A	1.82e-05	215	77	7	int:ZC3H7A
Interaction	ZNF148 interactions	POU6F2 SEC24C MKI67 USP54 CIC EP300	1.87e-05	144	77	6	int:ZNF148
Interaction	NCOA6 interactions	MED15 SMG7 MKI67 WWTR1 CREBBP EP300	1.95e-05	145	77	6	int:NCOA6
Interaction	DAZL interactions	ATXN2L UBAP2 SMG7 ATXN2 R3HDM1 PRRC2A	1.95e-05	145	77	6	int:DAZL
Interaction	SP7 interactions	WBP11 GSE1 ARID2 SIN3A ARID1A CREBBP CIC EP300	2.09e-05	304	77	8	int:SP7
Interaction	ELF5 interactions	ARID2 MKI67 SIN3A ARID1A EP300 EMSY	2.11e-05	147	77	6	int:ELF5
Interaction	TFAP2D interactions	TNS2 WWTR1 USP54 CREBBP EP300	2.31e-05	89	77	5	int:TFAP2D
Interaction	CTBP1 interactions	MED15 PHC3 SEC24C CTBP2 SIN3A MAML2 CREBBP CIC EP300	2.41e-05	406	77	9	int:CTBP1
Interaction	CEBPB interactions	ATXN2L TICRR PHC3 WBP11 SEC24C SIPA1L1 MKI67 AFF1 CTBP2 YBX3 SIN3A FOXJ3 CREBBP PRRC2A TOR1AIP1 CIC EP300	2.48e-05	1443	77	17	int:CEBPB
Interaction	UNK interactions	ATXN2L TSC22D1 UBAP2 SMG7 ATXN2 SIN3A R3HDM1 ARID1A PRRC2A	2.50e-05	408	77	9	int:UNK
Interaction	DYRK1B interactions	SIPA1L1 CTBP2 CREBBP CIC EP300	2.57e-05	91	77	5	int:DYRK1B
Interaction	KLF3 interactions	GSE1 ARID2 CTBP2 ARID1A CIC EP300 EMSY	2.66e-05	228	77	7	int:KLF3
Interaction	SOX10 interactions	POU6F2 ARID2 ARID1A CIC EP300	2.71e-05	92	77	5	int:SOX10
Interaction	FOXI1 interactions	GSE1 USP54 ARID1A CREBBP EP300	2.71e-05	92	77	5	int:FOXI1
Interaction	CPEB4 interactions	UBAP2 SMG7 ATXN2 USP54 R3HDM1 PRRC2A	2.94e-05	156	77	6	int:CPEB4
Interaction	RUNX1 interactions	CTBP2 WWTR1 SIN3A ARID1A CREBBP PRRC2A CIC EP300	3.29e-05	324	77	8	int:RUNX1
Interaction	TP53BP1 interactions	MED15 POU6F2 UBAP2 WWTR1 SIN3A ARID1A CREBBP CIC EP300 EMSY	3.44e-05	533	77	10	int:TP53BP1
Interaction	MAML2 interactions	MAML2 CREBBP EP300	3.51e-05	17	77	3	int:MAML2
Interaction	RNF43 interactions	SMG7 ATXN2 MKI67 YBX3 USP54 R3HDM1 ARID1A TOR1AIP1 TAB3	3.57e-05	427	77	9	int:RNF43
Interaction	SS18L1 interactions	ARID2 USP54 ARID1A CREBBP EP300	3.67e-05	98	77	5	int:SS18L1
Interaction	MCRIP2 interactions	ATXN2L PHC3 ATXN2 PRRC2A	4.30e-05	51	77	4	int:MCRIP2
Interaction	ARNT2 interactions	PDE4DIP NR4A3 WWTR1 SIN3A CREBBP	4.45e-05	102	77	5	int:ARNT2
Interaction	DYRK1A interactions	SEC24C SIPA1L1 MKI67 AFF1 TNS2 YBX3 USP54 CREBBP CIC EP300	4.63e-05	552	77	10	int:DYRK1A
Interaction	ING1 interactions	SIN3A ARID1A CREBBP CIC EP300	4.67e-05	103	77	5	int:ING1
Interaction	EGR2 interactions	ARID2 PDE4DIP ARID1A CREBBP EP300 EMSY	4.92e-05	171	77	6	int:EGR2
Interaction	ARNT interactions	SMG7 NR4A3 WWTR1 SIN3A CREBBP CIC EP300	5.41e-05	255	77	7	int:ARNT
Interaction	TLX1 interactions	GSE1 AUTS2 ARID1A CREBBP CIC EP300	5.60e-05	175	77	6	int:TLX1
Interaction	LDB2 interactions	NR4A3 SIN3A CREBBP EP300	6.22e-05	56	77	4	int:LDB2
Interaction	YWHAH interactions	FAM171A1 ATXN2L TICRR UBAP2 STARD9 SIPA1L1 TNS2 WWTR1 USP54 R3HDM1 MAP3K6 CREBBP CIC TAB3	6.52e-05	1102	77	14	int:YWHAH
Interaction	PAX8 interactions	GSE1 ARID1A CREBBP CIC EP300	6.67e-05	111	77	5	int:PAX8
Interaction	ZFP36 interactions	SMG7 ATXN2 TTC31 USP54 R3HDM1 PRRC2A	6.75e-05	181	77	6	int:ZFP36
Interaction	KLF13 interactions	SIN3A CREBBP EP300	6.79e-05	21	77	3	int:KLF13
Interaction	TBXT interactions	GSE1 ARID1A CREBBP CIC EP300	8.23e-05	116	77	5	int:TBXT
Interaction	NFIA interactions	MED15 GSE1 ARID1A CREBBP CIC EP300	8.33e-05	188	77	6	int:NFIA
Interaction	HNF4A interactions	GSE1 ARID2 ARID1A CREBBP CIC EP300 EMSY	8.69e-05	275	77	7	int:HNF4A
Interaction	ARID1A interactions	SMG7 ARID2 WWTR1 SIN3A ARID1A CREBBP EP300	8.89e-05	276	77	7	int:ARID1A
Interaction	CREBBP interactions	SMG7 NR4A3 CTBP2 WWTR1 SIN3A MAML2 PPP1R13L ARID1A CREBBP EP300	9.13e-05	599	77	10	int:CREBBP
Interaction	HOXA10 interactions	WWTR1 CREBBP CIC EP300	9.29e-05	62	77	4	int:HOXA10
Interaction	DDIT3 interactions	ARID2 ARID1A CREBBP EP300 EMSY	9.66e-05	120	77	5	int:DDIT3
Interaction	SMC5 interactions	ATXN2L PHC3 WBP11 UBAP2 ATXN2 ARID2 MKI67 YBX3 ARID1A PRRC2A TOR1AIP1 CIC EMSY	9.79e-05	1000	77	13	int:SMC5
Interaction	ETS1 interactions	ARID2 ARID1A CREBBP EP300 EMSY	1.00e-04	121	77	5	int:ETS1
Interaction	SIN3A interactions	GSE1 NR4A3 WWTR1 SIN3A ARID1A CREBBP CIC EP300	1.00e-04	380	77	8	int:SIN3A
Interaction	NR6A1 interactions	NR4A3 CREBBP EP300	1.02e-04	24	77	3	int:NR6A1
Interaction	PAX7 interactions	GSE1 ARID1A CREBBP CIC EP300	1.13e-04	124	77	5	int:PAX7
Interaction	PUM1 interactions	ATXN2L UBAP2 SMG7 ATXN2 R3HDM1 PRRC2A EP300	1.13e-04	287	77	7	int:PUM1
Interaction	GATA2 interactions	GSE1 ARID2 ARID1A CREBBP CIC EP300	1.14e-04	199	77	6	int:GATA2
Interaction	CELF1 interactions	WBP11 UBAP2 SMG7 ATXN2 YBX3 R3HDM1 PRRC2A	1.16e-04	288	77	7	int:CELF1
Interaction	HOXC8 interactions	POU6F2 PDE4DIP TNS2 USP54 ECM1	1.17e-04	125	77	5	int:HOXC8
Interaction	PRRC2A interactions	UBAP2 SMG7 ATXN2 WWTR1 YBX3 USP54 R3HDM1 PRRC2A	1.18e-04	389	77	8	int:PRRC2A
Interaction	RBBP7 interactions	GSE1 WWTR1 YBX3 SIN3A ARID1A CREBBP CIC EP300 EMSY	1.33e-04	507	77	9	int:RBBP7
Interaction	FHL2 interactions	ATXN2L PHC3 POU6F2 ODAM SIN3A CREBBP EP300 EMSY	1.34e-04	396	77	8	int:FHL2
Interaction	FUS interactions	ATXN2L PRMT8 UBAP2 GSE1 ARID2 MKI67 YBX3 ARID1A CREBBP PRRC2A EP300	1.36e-04	757	77	11	int:FUS
Interaction	FUBP3 interactions	SMG7 ATXN2 MKI67 USP54 R3HDM1 PRRC2A EP300	1.40e-04	297	77	7	int:FUBP3
Interaction	NR4A3 interactions	NR4A3 SIN3A CREBBP EP300	1.41e-04	69	77	4	int:NR4A3
Interaction	TENT5B interactions	POU6F2 UBAP2 TNS2 USP54	1.41e-04	69	77	4	int:TENT5B
Interaction	RBMS1 interactions	ATXN2L UBAP2 SMG7 ATXN2 R3HDM1 PRRC2A	1.41e-04	207	77	6	int:RBMS1
Interaction	UBAP2L interactions	MED15 ATXN2L UBAP2 SMG7 ATXN2 R3HDM1 PRRC2A	1.43e-04	298	77	7	int:UBAP2L
Interaction	POLR1H interactions	ATXN2 TNS2 CTBP2 CIC	1.49e-04	70	77	4	int:POLR1H
Interaction	YTHDF1 interactions	UBAP2 SMG7 ATXN2 MKI67 ZKSCAN8 R3HDM1 PRRC2A	1.55e-04	302	77	7	int:YTHDF1
Interaction	MYB interactions	SIN3A CREBBP CIC EP300 EMSY	1.57e-04	133	77	5	int:MYB
Interaction	EWSR1 interactions	MED15 WBP11 PRMT8 SEC24C CSRP2 MKI67 R3HDM1 ARID1A CREBBP PRRC2A CIC EP300	1.57e-04	906	77	12	int:EWSR1
Interaction	MAML1 interactions	SMG7 MAML2 CREBBP EP300	1.76e-04	73	77	4	int:MAML1
Interaction	MDC1 interactions	ATXN2 CSRP2 MKI67 SIN3A ARID1A CREBBP EP300 EMSY	1.81e-04	414	77	8	int:MDC1
Interaction	FOS interactions	ARID2 NR4A3 SIN3A ARID1A CREBBP CIC EP300	1.90e-04	312	77	7	int:FOS
Interaction	GUSBP5 interactions	SMG7 GSE1 ATXN2 EMSY	1.95e-04	75	77	4	int:GUSBP5
Interaction	BMI1 interactions	ATXN2L PHC3 WBP11 ATXN2 CSRP2 MKI67 YBX3 CREBBP PRRC2A EP300	1.99e-04	659	77	10	int:BMI1
Interaction	FMR1 interactions	FAM171A1 ATXN2L UBAP2 SMG7 ATXN2 MKI67 R3HDM1 PRRC2A EMSY	2.01e-04	536	77	9	int:FMR1
Interaction	SOX15 interactions	GSE1 ARID2 ARID1A CIC EP300	2.06e-04	141	77	5	int:SOX15
Interaction	ERG interactions	GSE1 ARID1A CREBBP CIC EP300 EMSY	2.11e-04	223	77	6	int:ERG
Interaction	E2F4 interactions	ATXN2L SIPA1L1 CSRP2 YBX3 SIN3A PPP1R13L ARID1A TOR1AIP1 EP300	2.13e-04	540	77	9	int:E2F4
Cytoband	16p13.11	NPIPA5 NPIPA1 NPIPA3	1.06e-05	23	85	3	16p13.11
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	NPIPA5 NPIPA1 NPIPA3 NPIPA7 TNP2 CREBBP NPIPB2	1.49e-05	426	85	7	chr16p13
Cytoband	Ensembl 112 genes in cytogenetic band chr16p12	NPIPB7 NPIPB4 NPIPB3 NPIPB5 NPIPA8	1.79e-05	172	85	5	chr16p12
Cytoband	16p12.2	NPIPB4 NPIPB3 NPIPB5	4.55e-05	37	85	3	16p12.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p11	ATXN2L NPIPB13 NPIPB12 NPIPB9 NPIPB11	1.73e-04	278	85	5	chr16p11
Cytoband	16p11.2	NPIPB7 NPIPB13 NPIPB12 NPIPB11	4.52e-04	191	85	4	16p11.2
Cytoband	16p13.13	TNP2 NPIPB2	6.30e-04	20	85	2	16p13.13
Cytoband	2p13.1	TTC31 C2orf78	1.83e-03	34	85	2	2p13.1
Cytoband	10q22.2	SEC24C USP54	2.65e-03	41	85	2	10q22.2
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3A EMSY	2.95e-04	12	39	2	1243
GeneFamily	AT-rich interaction domain containing	ARID2 ARID1A	4.68e-04	15	39	2	418
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	6.04e-04	17	39	2	486
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	6.79e-04	18	39	2	91
GeneFamily	Ataxins\|Trinucleotide repeat containing	MED15 ATXN2	1.32e-03	25	39	2	775
GeneFamily	PDZ domain containing	CNKSR1 SIPA1L1 PDZD2	4.27e-03	152	39	3	1220
GeneFamily	Sterile alpha motif domain containing	PHC3 CNKSR1	1.54e-02	88	39	2	760
GeneFamily	SH2 domain containing	TNS2 TNS4	2.00e-02	101	39	2	741
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	PHC3 GSE1 SEC24C AUTS2 CTBP2 ALPK1 PPP1R13L	2.87e-06	197	82	7	M4421
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	GSE1 MKI67 AUTS2 AFF1 CTBP2 NPIPB5 FOXJ3 CREBBP	4.59e-06	300	82	8	M8702
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	ROBO4 CSRP2 MYRIP AFF1 TNS2 NR4A3 NPIPB3 WWTR1 YBX3 USP54 NPIPB5 ECM1	1.99e-05	888	82	12	M39049
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TICRR UBAP2 SIPA1L1 ARID1A CREBBP EP300	2.19e-05	180	82	6	M8239
Coexpression	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	ATXN2L PRMT8 GSE1 TNS4 MAP3K6 PDZD2	3.96e-05	200	82	6	M5019
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP	NPIPB15 NPIPA1 EP300	4.35e-05	22	82	3	M40867
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_DN	TSC22D1 CSRP2 MYRIP TNS2 SYNPO ECM1	5.62e-05	213	82	6	M12176
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1	FAM171A1 ROBO4 TSC22D1 CSRP2 TNS2 NPIPB3 WWTR1 ECM1	7.12e-05	440	82	8	M39039
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	FAM171A1 GSE1 ATXN2 SIPA1L1 AFF1 NPIPB3 CTBP2 WWTR1 R3HDM1 FOXJ3 CREBBP	7.15e-05	856	82	11	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	FAM171A1 ATXN2 AFF1 CTBP2 R3HDM1 NPIPB5 FOXJ3 CREBBP	1.06e-04	466	82	8	M13522
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TICRR MKI67 NPIPA1 SYNPO MAP3K6 EMSY	8.20e-07	167	85	6	3461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NPIPB4 SIPA1L1 AFF1 NPIPB3 MAML2 NPIPB5	1.90e-06	193	85	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	ILEUM-inflamed-(7)_CD36+_endothelial_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ROBO4 TSC22D1 MYRIP TNS2 WWTR1 SYNPO	2.21e-06	198	85	6	05d6558c7990ad2277db999025a073d29b273dfc
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 MYRIP TNS2 WWTR1 SYNPO YBX3	2.34e-06	200	85	6	cd3c638961144a2fc91c437a173cc37c7452fa74
ToppCell	distal-Endothelial-Vein-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM171A1 CSRP2 MYRIP AFF1 WWTR1 MAP3K6	2.34e-06	200	85	6	ff88d28162e0231d5dac0e0c6bec98fa8da58a23
ToppCell	Control-Developping_Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SPATA3 TICRR NPIPB7 MKI67 MYRIP	3.43e-06	120	85	5	695dab6b01ad2c33cdcaf92bb9996ff2899ef77e
ToppCell	Control-Lymphocyte-B-Plasmablast\|Control / Disease, Lineage and Cell Type	CNKSR1 NPIPB15 MKI67 GPR152 NPIPA3	1.48e-05	162	85	5	67b32c40cc180c5ebbfd901a417b5be469500110
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	NPIPA1 SYNPO MAP3K6 PRRC2A EMSY	1.57e-05	164	85	5	d7053de88ef8e42cac6726a40e72f212659ee034
ToppCell	Multiple_Sclerosis-Lymphocyte-B-Plasmablast\|Multiple_Sclerosis / Disease, Lineage and Cell Type	CNKSR1 NPIPB15 NPIPA5 MKI67 NPIPA8	2.09e-05	174	85	5	e8d2aa9505817aac3fe068080774d19458f07b01
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MYRIP WWTR1 SYNPO YBX3 PDZD2	2.73e-05	184	85	5	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	2.87e-05	186	85	5	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	PHC3 ARID2 ZKSCAN8 CREBBP EP300	2.87e-05	186	85	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L NR4A3 SYNPO YBX3 PRRC2A	3.10e-05	189	85	5	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.26e-05	191	85	5	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	10x5'v1-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.51e-05	194	85	5	e141beafc9252e5d8c949252bfab53e127c881dc
ToppCell	10x5'v1-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.51e-05	194	85	5	953578102ffc7b612ee8fce45e414750800fef5d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CNKSR1 UBAP2 LRRC37A2 NPIPA1 MAML2	3.51e-05	194	85	5	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CNKSR1 UBAP2 LRRC37A2 NPIPA1 MAML2	3.51e-05	194	85	5	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	Cerebellum-Endothelial\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TSC22D1 CSRP2 TNS2 WWTR1 ECM1	3.60e-05	195	85	5	2192fd9b4682054776f0716933aed5a4a9412657
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 SIPA1L1 AUTS2 MAML2 PDZD2	3.69e-05	196	85	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ROBO4 MYRIP AUTS2 CTBP2 WWTR1	3.69e-05	196	85	5	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 MYRIP TNS2 WWTR1 YBX3	3.78e-05	197	85	5	e8e879b7634a29569061d3515d180784094a31e7
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 TNS2 WWTR1 SYNPO MAP3K6	3.78e-05	197	85	5	c29ed0e706999d4c2b93e6e3bf46c42aeceb4813
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM171A1 ROBO4 CSRP2 MYRIP WWTR1	3.78e-05	197	85	5	7a1a3839b2c965136663241b0d4e96c64cfb656a
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ROBO4 TSC22D1 NPIPB4 CSRP2 TNS2	3.87e-05	198	85	5	0a4626b51ba8b52acbaf616f0ced850079cd7149
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	FAM171A1 ROBO4 CSRP2 WWTR1 SYNPO	3.87e-05	198	85	5	f83956c4b13b5d0a0c6e3d9f580dbf99649ef175
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|tumor_Lung / Location, Cell class and cell subclass	FAM171A1 ROBO4 MYRIP WWTR1 SYNPO	3.87e-05	198	85	5	5228c4bf2513186140c2c4eaa67a268c732bdc84
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.87e-05	198	85	5	122215d9288533ad03562cf777e846504863df9a
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.87e-05	198	85	5	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 SIPA1L1 AUTS2 MAML2 PDZD2	3.87e-05	198	85	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)\|390C / Donor, Lineage, Cell class and subclass (all cells)	FAM171A1 ROBO4 CSRP2 WWTR1 SYNPO	3.87e-05	198	85	5	5b5ccce5de82ea041465e656147cec3b8beb865b
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 AUTS2 AFF1 MAML2 INO80D	3.96e-05	199	85	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	5'-Adult-LargeIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.96e-05	199	85	5	ffebd99d55d31cf51b4878b2690ed0b9b3799223
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 MYRIP TNS2 WWTR1 SYNPO	3.96e-05	199	85	5	258d59cf811bf1668ffbb5f18f961021f660de62
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STARD9 CSRP2 TNS2 ECM1 PDZD2	4.06e-05	200	85	5	d70bad979299615fcba707ba21296020918705e6
ToppCell	ILEUM-non-inflamed-(7)_CD36+_endothelial_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ROBO4 TSC22D1 TNS2 WWTR1 SYNPO	4.06e-05	200	85	5	45755a597725015dc3ee36f9166f9e82f6f9c603
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STARD9 CSRP2 TNS2 ECM1 PDZD2	4.06e-05	200	85	5	38c21ec379005f688df33aea65237a063c476c2e
ToppCell	5'-Adult-SmallIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 TNS2 WWTR1 SYNPO YBX3	4.06e-05	200	85	5	2554b77edfe3d378296b0b25625caacbfb1c0e76
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GSE1 SIPA1L1 NPIPA1 YBX3	5.88e-05	110	85	4	bc1986e5a496a4d25da3445b6f252f81741619f4
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ARID2 ALPK1 USP54 ECM1	1.50e-04	140	85	4	0e1e9281de87df178ac41ed6b697b4fa09be2749
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NPIPB13 NR4A3 MAP3K6 NPIPB2	1.54e-04	141	85	4	737237db115721524c44ea4c55aed000e1b00ee5
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPIPB13 NR4A3 MAP3K6 NPIPB2	1.54e-04	141	85	4	c14f84bc3921cafbce6fa7f7163ecf3cd9cdf073
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TSC22D1 CSRP2 AUTS2 R3HDM1	1.85e-04	148	85	4	a1269312903fc27830c1835dabf660c659a711be
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|356C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A NPIPB4 SEC24C LRRC37A2	2.74e-04	164	85	4	d5bb57c321f2973836efc8990449494cc1fb87c7
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SMG7 ARID1A FOXJ3 INO80D	2.87e-04	166	85	4	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	moderate-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ROBO4 TSC22D1 NPIPB15 INKA1	2.87e-04	166	85	4	c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR LRRC37A NPIPB13 CNTNAP1	2.87e-04	166	85	4	26f3d5e5e30b63b09b89cda23c423d12d887631f
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 CSRP2 MYRIP WWTR1	2.93e-04	167	85	4	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AUTS2 CTBP2 MAP3K6 CIC	3.00e-04	168	85	4	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CNKSR1 LRRC37A2 NPIPA1 MAML2	3.07e-04	169	85	4	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CNKSR1 LRRC37A2 NPIPA1 MAML2	3.07e-04	169	85	4	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CSRP2 TNS4 PPP1R13L INKA1	3.14e-04	170	85	4	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CSRP2 TNS4 PPP1R13L INKA1	3.14e-04	170	85	4	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 CSRP2 MYRIP NPIPA7	3.21e-04	171	85	4	b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FAM171A1 CSRP2 MYRIP PDZD2	3.21e-04	171	85	4	3112d15f2a28cf4a71992db4971d960716dc1264
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR UBAP2 MYRIP SYNPO	3.28e-04	172	85	4	8a6a2b4c6654bc976e60a02d0e7303a9071ed55f
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSE1 MYRIP ECM1 MAP3K6	3.35e-04	173	85	4	a5b6c3d58f7a8e533330798b81496009a31548af
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSE1 MYRIP ECM1 MAP3K6	3.35e-04	173	85	4	cc094992b8027f4cef38f0fb0b76f0d07210d1e2
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A NPIPB4 SEC24C LRRC37A2	3.35e-04	173	85	4	090dc3c5bd2652a65c2490fc889da858c3af368f
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A NPIPB4 SEC24C LRRC37A2	3.43e-04	174	85	4	a79ebb01a5849c314e02594a9c95009dbb03cb8c
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D231\|Adult / Lineage, Cell type, age group and donor	FAM171A1 ROBO4 MYRIP WWTR1	3.43e-04	174	85	4	2dd647c4fdf99fd1f7b838efef01baf2cbc3446d
ToppCell	droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYRIP SERPINA10 USP54 MAP3K6	3.58e-04	176	85	4	533d544852038c0612aacf87f4b1c88ff7aace82
ToppCell	facs-Aorta-Heart-24m-Endothelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 WWTR1 TNP2 INKA1	3.66e-04	177	85	4	c6b955765aee8a196fcf4f7bb16139c95b76dc4e
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TICRR NPIPB15 NPIPB9 MKI67	3.66e-04	177	85	4	d2c1f46913ac00bbc0bb9320d5652edc01b34179
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TICRR NPIPB15 NPIPB9 MKI67	3.66e-04	177	85	4	65e090aad0ffb737ce034e25bd5b12a0b1dd9684
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	AUTS2 NR4A3 NPIPB3 YBX3	3.66e-04	177	85	4	84930899eb2978598bc8a351cbcd9e714e46799d
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FAM171A1 CSRP2 MYRIP YBX3	3.74e-04	178	85	4	0139b42494c1186390b12106dea7957e2b6717c2
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNS2 WWTR1 INKA1 PDZD2	3.74e-04	178	85	4	c30d3390fc4a7856f50ba8ff6694c0333165ddde
ToppCell	normal-na-Lymphocytic_B-plasmablast-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 NPIPB15 NPIPB9 MKI67	3.74e-04	178	85	4	40a280c1e35963dd45d1809a3e85b568344dd1f5
ToppCell	normal-na-Lymphocytic_B-plasmablast\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 NPIPB15 NPIPB9 MKI67	3.74e-04	178	85	4	4fe87c713770173336177e3488f7b4a3be54f71b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 TNS4 PPP1R13L ECM1	3.98e-04	181	85	4	a5e770b5b5d57cbac18560828e89f7c96b687743
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 TNS4 PPP1R13L ECM1	3.98e-04	181	85	4	504b1af1951a7a20ef5db69d84c20630ec64095b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 TNS4 PPP1R13L ECM1	3.98e-04	181	85	4	a55ec36d2393f7a376feb42b22aee75dfdf4c383
ToppCell	wk_15-18-Mesenchymal-Chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	KCNU1 COL27A1 PDE4DIP AUTS2	3.98e-04	181	85	4	8950844b3e65c7028d80da5787ae2ce509c3d52d
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ROBO4 CSRP2 MYRIP PDZD2	4.06e-04	182	85	4	345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 MYRIP TNS2 WWTR1	4.15e-04	183	85	4	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM171A1 CSRP2 MYRIP TNS2	4.15e-04	183	85	4	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	d31d4116d1d196633784863781fa45673607a421
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL27A1 SIPA1L1 R3HDM1 PDZD2	4.23e-04	184	85	4	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL27A1 SIPA1L1 R3HDM1 PDZD2	4.23e-04	184	85	4	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	MED15 MKI67 NPIPA3 EMSY	4.23e-04	184	85	4	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	Control-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	SIPA1L1 AUTS2 NR4A3 CTBP2	4.32e-04	185	85	4	520795866d44def5be3910ce8e728045c716a24d
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ATXN2L SIPA1L1 NPIPB5 TAB3	4.41e-04	186	85	4	76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L NR4A3 YBX3 PRRC2A	4.41e-04	186	85	4	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	ATXN2 COL27A1 R3HDM1 ARID1A	4.41e-04	186	85	4	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ATXN2 COL27A1 R3HDM1 ARID1A	4.41e-04	186	85	4	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 NPIPB15 NPIPB9 MKI67	4.50e-04	187	85	4	88d20f150df61ef0e3ee0c3e9895b094920c4b09
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A1 WWTR1 SYNPO INKA1	4.50e-04	187	85	4	3548a9914c2b2f5d805798ce22ab26eab6d03897
ToppCell	Control-Myeloid-DC_Mature\|Control / Disease state, Lineage and Cell class	NPIPA1 AUTS2 NR4A3 NPIPA7	4.50e-04	187	85	4	049780ca2a3e6adcd89dc2cf3095b5ad068b244a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 NPIPB15 NPIPB9 MKI67	4.50e-04	187	85	4	158c2c003fd225ba61793fb06eece232fb063d05
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A1 WWTR1 SYNPO INKA1	4.50e-04	187	85	4	f4de4b7af1fdfbd628b1f509c060c1079d2e5437
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A1 WWTR1 SYNPO INKA1	4.50e-04	187	85	4	81754e965848b718be20ee97ce072ce426938a69
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CSRP2 TNS2 WWTR1 ECM1	4.59e-04	188	85	4	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 POU6F2 NPIPB9 MKI67	4.59e-04	188	85	4	ecba5d06cbf3254448255a2aeefffe711f43310e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CNKSR1 POU6F2 NPIPB9 MKI67	4.59e-04	188	85	4	8cf135da4d1d2500755d2809d60b41509af9fa8b
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A	SIPA1L1 PDE4DIP TNS2 NR4A3 R3HDM1 PPP1R13L ARID1A TNP2 PDZD2	1.72e-08	189	78	9	3072_UP
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ATXN2L CNTNAP1 TNS2 SYNPO ALPK1 INO80D CIC	5.48e-06	199	78	7	578_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	UBAP2 SMG7 TNS2 ALPK1 ARID1A INO80D EMSY	5.66e-06	200	78	7	4824_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	MED15 ATXN2L MKI67 TNS2 CREBBP INO80D	5.47e-05	194	78	6	3861_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	SMG7 PDE4DIP SYNPO ALPK1 ARID1A EMSY	5.47e-05	194	78	6	6642_DN
Drug	Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A	MED15 CNKSR1 SMG7 WWTR1 ARID1A INO80D	5.62e-05	195	78	6	6266_DN
Drug	Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A	MED15 ATXN2L CNTNAP1 ARID1A EMSY PDZD2	5.62e-05	195	78	6	4418_DN
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A	PDE4DIP ZKSCAN8 AFF1 TNS4 INO80D TOR1AIP1	5.79e-05	196	78	6	4600_UP
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A	GSE1 ATXN2 AFF1 ALPK1 ARID1A PRRC2A	5.95e-05	197	78	6	2034_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ROBO4 PRMT8 ADAM29 ARID1A ECM1 PDZD2	6.12e-05	198	78	6	2269_UP
Drug	probucol; Down 200; 10uM; MCF7; HG-U133A	FAM171A1 ATXN2L AFF1 TNS2 TNS4 ECM1	6.12e-05	198	78	6	592_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	PHC3 SMG7 PDE4DIP SYNPO ALPK1 ARID1A	6.12e-05	198	78	6	3681_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A	TSC22D1 ATXN2 MKI67 AFF1 PRRC2A CIC	6.29e-05	199	78	6	122_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; HL60; HG-U133A	ROBO4 ATXN2 TTC31 MKI67 PPP1R13L ECM1	6.29e-05	199	78	6	1718_DN
Disease	alcohol use disorder (implicated_via_orthology)	KCNU1 ARID2 AUTS2 CTBP2 ARID1A CREBBP EP300	6.71e-07	195	75	7	DOID:1574 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	LRRC37A SIPA1L1 LRRC37A2 MKI67 AFF1 USP54 ARID1A MAP3K6 PRRC2A TOR1AIP1 CIC EP300 EMSY	2.86e-06	1074	75	13	C0006142
Disease	Menke-Hennekam syndrome	CREBBP EP300	6.37e-06	2	75	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	6.37e-06	2	75	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	6.37e-06	2	75	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	6.37e-06	2	75	2	C4551859
Disease	spinocerebellar ataxia type 2 (implicated_via_orthology)	ATXN2L ATXN2	6.37e-06	2	75	2	DOID:0050955 (implicated_via_orthology)
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	6.37e-06	2	75	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	6.37e-06	2	75	2	cv:C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	6.37e-06	2	75	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	6.37e-06	2	75	2	C0035934
Disease	Burkitt Lymphoma	AUTS2 AFF1 ARID1A	1.06e-04	36	75	3	C0006413
Disease	severe acute respiratory syndrome, COVID-19	MED15 PDE4DIP MYRIP AUTS2 CTBP2 MAML2 PDZD2	1.43e-04	447	75	7	EFO_0000694, MONDO_0100096
Disease	Carcinoma, Transitional Cell	ARID1A CREBBP EP300	1.57e-04	41	75	3	C0007138
Disease	AUTISM, SUSCEPTIBILITY TO, 15	AUTS2 SIN3A	1.77e-04	8	75	2	C2677504
Disease	alopecia areata	GSE1 ATXN2 EMSY	2.84e-04	50	75	3	EFO_0004192
Disease	Abnormality of refraction	POU6F2 HCN1 ARID2 AUTS2 AFF1 CTBP2 YBX3 TOR1AIP1	3.09e-04	673	75	8	HP_0000539
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN2	4.14e-04	12	75	2	DOID:1441 (implicated_via_orthology)
Disease	pre-eclampsia (is_marker_for)	ROBO4 ARID1A CREBBP	4.40e-04	58	75	3	DOID:10591 (is_marker_for)
Disease	Coffin-Siris syndrome	ARID2 ARID1A	4.88e-04	13	75	2	C0265338
Disease	T-Cell Lymphoma	ARID1A EP300	7.48e-04	16	75	2	C0079772
Disease	Precursor B-cell lymphoblastic leukemia	AUTS2 AFF1	1.30e-03	21	75	2	C1292769
Disease	serotonin measurement	AUTS2 WWTR1	1.42e-03	22	75	2	EFO_0004846
Disease	prostate carcinoma	PHC3 WBP11 UBAP2 CTBP2 INO80D TOR1AIP1 EMSY TAB3	1.90e-03	891	75	8	EFO_0001663
Disease	grip strength measurement	ATXN2L POU6F2 AUTS2 R3HDM1 PRRC2A	2.00e-03	350	75	5	EFO_0006941
Disease	Colorectal Carcinoma	GSE1 ODAM MKI67 ADAM29 TNS4 ARID1A EP300	2.05e-03	702	75	7	C0009402
Disease	mosquito bite reaction size measurement	UBAP2 AUTS2 R3HDM1 EMSY	2.11e-03	212	75	4	EFO_0008378
Disease	Adenoid Cystic Carcinoma	ARID1A CREBBP EP300	2.14e-03	100	75	3	C0010606
Disease	Sezary Syndrome	ARID1A CREBBP	2.15e-03	27	75	2	C0036920
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	ATXN2 AFF1 ARID1A	2.32e-03	103	75	3	EFO_0008595, EFO_0020944
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L POU6F2 KCNU1 AUTS2 PRRC2A	2.37e-03	364	75	5	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Breast Carcinoma	LRRC37A LRRC37A2 MKI67 ARID1A EP300 EMSY	2.49e-03	538	75	6	C0678222

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQPPVTPSQSHPQVM	ADAM29	741	Q9UKF5
QSQPPVMPSQSHPQL	ADAM29	776	Q9UKF5
SHPQLTPSQSQPPVT	ADAM29	786	Q9UKF5
TPSQSQPPVTPSQRQ	ADAM29	791	Q9UKF5
TTPTGQQPTTPQTPQ	EP300	1856	Q09472
QVPTPTAAPNQAPAS	CNTNAP1	1341	P78357
NLPTVAHPSQAPSPN	CTBP2	416	P56545
ATQPSSANPTQPTVP	C2orf78	791	A6NCI8
PELQSSSRAPPPQHN	GSE1	1066	Q14687
SSRAPPPQHNGQQEP	GSE1	1071	Q14687
PPSPAVQVQGQPNSS	ARID2	1596	Q68CP9
PPSVATPQSSQQQPT	CREBBP	936	Q92793
AESTEVNSPPSQPPQ	PRMT8	21	Q9NR22
HQPQPATTPTGSQPQ	ATXN2L	871	Q8WWM7
GSQPQSQHAAPSPVQ	ATXN2L	881	Q8WWM7
QQQMPLTPFSPHNTP	ALPK1	666	Q96QP1
QPPPPTQQHSITDNS	NPIPB3	246	Q92617
SVPNNPQSCAHSPPQ	R3HDM1	836	Q15032
QPPPPTQQHSIIDNS	NPIPA1	246	Q9UND3
QPPPPTQQHSITDNS	NPIPB12	246	F8W0I5
SQQPPSQTPHAQPSY	ARID1A	486	O14497
PHQQSPAPYPSQQST	ARID1A	526	O14497
PAPYPSQQSTTQQHP	ARID1A	531	O14497
PTSQTGPDVQPSHQL	INKA1	36	Q96EL1
FPHPSSQIQPQPLSS	FAM171A1	626	Q5VUB5
PTPGQDQAQHPVSPS	LRRC37A3	591	O60309
PTPGQDQAQHPVSPS	LRRC37A2	591	A6NM11
PTPGQDQAQHPVSPS	LRRC37A	591	A6NMS7
NRAPPPHQSTQSQPL	KTI12	251	Q96EK9
HPQPSATPTGQQQSQ	ATXN2	1146	Q99700
QSQTFPCPQAPSQHP	MAP3K6	941	O95382
TVPHSPPQPKTNLEN	PDZD2	1846	O15018
LQLQTPPQTQPGPSH	ODAM	111	A1E959
PPVQAHPSAQSLSQP	AUTS2	376	Q8WXX7
PQPGQPSSQPNSNVS	MED15	456	Q96RN5
LNPTAQPQSDPTAQP	GPR152	376	Q8TDT2
QPPPPTQQHSITDNS	NPIPB5	246	A8MRT5
SPPPQPSSNQTLVDT	KCNU1	801	A8MYU2
PCQSLQPEPINTPTH	MKI67	1006	P46013
QPPPPTQQHSITDNS	NPIPB7	246	O75200
QPPPPTQQHSIIDNS	NPIPA3	246	F8WFD2
QPPPPTQQHSITDNS	NPIPB4	246	C9JG80
QPPPPTQQHSITDNS	NPIPB15	246	A6NHN6
PITLQNSTQDPPPSQ	PHC3	336	Q8NDX5
NSTQDPPPSQHCIPL	PHC3	341	Q8NDX5
PPAPSNAQSQHCSPI	PHC3	361	Q8NDX5
QSHPSPLTVSPNQSQ	PHC3	376	Q8NDX5
QPPPPTQQHCITDNS	NPIPB11	246	E5RHQ5
SSPIPSVPQSQAQPQ	MAML2	401	Q8IZL2
SNLHSPSPSTQTPQP	HCN1	676	O60741
KPESVQPHRPTTNPN	CSRP2	91	Q16527
QHQTLTHQAPPPPQQ	FOXJ3	431	Q9UPW0
THQAPPPPQQVSCNS	FOXJ3	436	Q9UPW0
TPTKPQRTSPTNPHQ	COL27A1	296	Q8IZC6
QEHFSPPPAPSQQQP	INO80D	191	Q53TQ3
GQSQVQPPPSQEATP	ECM1	71	Q16610
PSPVSHQQQPQQSPL	EMSY	426	Q7Z589
VSQPNHVSSPPQALP	SEC24C	241	P53992
QPQTPTPAPQHPQQT	PPP1R13L	431	Q8WUF5
QPPPPTQQHSITDNS	NPIPB9	261	F8W1W9
QPPPPTQQHSITDNS	NPIPB13	246	A6NJU9
QPPPPTQQHSIIDNS	NPIPA7	246	E9PJI5
QPPPPTQQHSIIDNS	NPIPA8	246	P0DM63
QHQQPSIPPASSPED	NR4A3	111	Q92570
SGHQSQSPNTSPPPK	TNP2	66	Q05952
PSPFSSPQHQVQPSQ	TAB3	301	Q8N5C8
QPPPPTQQHSIIDNS	NPIPA5	246	E9PKD4
SSHNPPATDVNQNPP	SYNPO	331	Q8N3V7
TNQHPQPAPQAPSQS	POU6F2	201	P78424
NQPSPTQQSSSPPQK	POU6F2	261	P78424
TQQSSSPPQKPSQSP	POU6F2	266	P78424
SQPPSQQPLTSLPAQ	SMG7	736	Q92540
PPCPEPSSVSHQQFQ	PPP1R32	281	Q7Z5V6
STAQPPESQPLPASQ	PRRC2A	101	P48634
PESQPLPASQTPASN	PRRC2A	106	P48634
PHSPQVPSQVQSPMT	SIPA1L1	1076	O43166
QPPPQHPSQPSAQSA	SIN3A	221	Q96ST3
STSQQPSPESTPQQP	SPATA3	26	Q8NHX4
PQQPSPESTPQHSSL	SPATA3	46	Q8NHX4
TTQPQGTTQPPAQPA	TSC22D1	1051	Q15714
SEKQEQSPPQPPNDH	STARD9	4171	Q9P2P6
QSPPQPPNDHSQDSE	STARD9	4176	Q9P2P6
PHETPPTQSQQTQPP	ROBO4	721	Q8WZ75
SPVPPLSPIHSNQQT	AFF1	206	P51825
PSQPDPSVQPSEAQQ	CIC	46	Q96RK0
PSVQPSEAQQPASHP	CIC	51	Q96RK0
PQTPPQVLDSPHQRS	CNKSR1	291	Q969H4
SPAPATTPAQPQQSQ	UBAP2	876	Q5T6F2
SHPAPQQPSQPVKDT	TICRR	891	Q7Z2Z1
EAPTENPAPPTQQSS	YBX3	356	P16989
QQQHSEQPPLQPSPV	TOR1AIP1	131	Q5JTV8
SPPQRTPGHQNSVQP	TNS4	386	Q8IZW8
MQAAAPPSSQPHPQQ	SOGA3	331	Q5TF21
PPSSQPHPQQLQEQE	SOGA3	336	Q5TF21
QPPPPTQQHSITDNS	NPIPB2	261	A6NJ64
PQSPETPAPQNQTSR	SERPINA10	26	Q9UK55
QTLSQSCTPPQSPQP	nan	96	Q8N9P0
ASSQQQAPPQSVPPS	WBP11	386	Q9Y2W2
HQGLPPSQPPFSSTQ	PRR30	41	Q53SZ7
PQTPEPPTQESQSNV	TNS2	1116	Q63HR2
PEPPNTQLQSEATQH	ZKSCAN8	161	Q15776
PNQPLSQTQSRRPHP	TTC31	481	Q49AM3
PSTLSQQNHPTQNPP	WWTR1	201	Q9GZV5
PQQPSQPSACLPTQA	USP54	871	Q70EL1
SNSNPISLPTPQNTP	PDE4DIP	1671	Q5VU43
PQPQPTQAQSSDQGP	MYRIP	421	Q8NFW9